trending Market Intelligence /marketintelligence/en/news-insights/trending/cjY6ZLCof98vCUF8DjxjMQ2 content esgSubNav
In This List

Gilead promotes executive to replace outgoing CFO

Blog

Insight Weekly: Unease roils markets; US likely to slip into recession; firms' cash ratios fall

Blog

Insight Weekly: Bank boards lag on gender parity; future of office in doubt; US LNG exports leap

Blog

Insight Weekly: Job growth faces hurdles; shale firms sit on cash pile; Africa's lithium future

Blog

Insight Weekly: Loan growth picks up; US-China PE deals fall; France faces winter energy crunch


Gilead promotes executive to replace outgoing CFO

Gilead Sciences Inc. named Andrew Dickinson its new CFO, replacing Robin Washington, effective Nov. 1.

Dickinson has been with the company since 2016 and is executive vice president, corporate development and strategy. He will continue with the role after he becomes CFO, Gilead said in an Oct. 15 release.

The executive led Gilead's 2017 acquisition of Kite Pharma Inc., and the $5.05 billion research collaboration with Galapagos NV that was announced in July, the company said. Dickinson served as global co-head of healthcare investment banking at Lazard Frères & Co. before joining Gilead.

Washington will remain with the company in an advisory capacity until early 2020 and will work with Dickinson during the transition.